Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • GIC Re Brings Global Reinsurance Leaders Together to Drive Resilient Growth at 29th FAIR Conference Business
  • Seraseal, World’s Most Advanced, Next Generation Hemostatic Technology, Now In India! Health
  • Anusaya Fresh, SanLucar and Mr. Iceman Join Hands to Bring the World’s Finest Blueberries to India Business
  • CSC and Amity University partner to offer higher education to lakhs of rural students Press Release
  • Siri Fort Sports Complex Celebrates Republic Day with a Cricket Spectacle of Unity and Team Spirit Business
  • Defile de Mode Season 3: A Spectacular Show by NSAM Institute National
  • Cable TV Show 2023 Kolkata gears up for three-day mega exhibition Business
  • How sustainability helped founder Nimit Singhi, to launch his brand Live Linen A

Riding High through Cannabis Medicine

Posted on November 15, 2022 By

New Delhi (India), November 15: The brand received its first 1000 orders in a relatively short amount of time and had three-fold growth in the previous two quarters. The brand has 8 SKUs on its wish list. Cannabis Leaf Extract Oil, Hemp Seed Oil, and Pain Massage Oil have witnessed a tremendous increase.

Cannarma, is a company pioneering in high-quality Cannabis based medicinal products like Cbd oil, hemp seed oil, Hemp pain relief massage oil & balm and Ayurvedic medicinal cannabis products. Multiple studies report that Cannabis has medicinal properties which are beneficial for people suffering from severe and chronic diseases. Licensed under Department of Ayush, it has ‘Make in India’ in its core. With focus on Research and Development, this company has introduced path breaking medicinal formulations for alleviating chronic pain.

Medicines of Cannarma follow stringent quality norms for manufacturing. They are tested and certified before getting introduced in market. Medicines formulations are available in form of pain massage oils, balms, and extract tinctures. Time tested ancient ayurvedic practices are used to prepare medicines. They are lab tested and are safe without any side effects. From raw materials to production, everything is followed as per certified processes. Cannarma has now on boarded medicinal experts for facilitating consultation services to the customers. With technological advancement, patients can consult medical professionals remotely and get prescriptions online.

Rohit Chauhan and Keshav Agarwal co-founded Cannarma with aim to provide therapeutic values of medicinal properties of Cannabis which were neglected in India since long. Rohit is a Cannabis Phytocannabinoid Extraction & Analysis Researcher & Life Time Scientific Member of Italian Society of Medicinal Cannabis. Rohit who has masters in Biodiversity & Environmental Health with specialization in Cannabis Plant Science from University of Siena, Italy, teamed with Keshav Agarwal to introduce line of pharmaceuticals medicines which are 100% natural without any chemicals or solvents.

Keshav Agarwal through his business acumen helped branding and launching of Cannarma. He is from family which is into Textile Business Since 1962 (DORA GROUP). Keshav, who wanted to help people have better lives, was researching on Cannabis for a long time. He interacted with many Professors, PhD students, researchers globally. Eventually he understood how the Endocannabinoid systems in the body bind with the cannabinoids by activating the CB1 and CB2 receptors which are responsible for a better sleep, Pain management and Immunity. Along with Cannarma, Rohit Chauhan and Keshav Agarwal are also the co-founder of Incare Lab.

In the beginning, Cannarma had to face many challenges. Company had to abide by many Industry regulations and address the stigma around Cannabis. This was an unexplored territory in plant and medicinal sciences. Though Cannabis based medicines are in vogue in western countries this was unheard of in India. Cannarma envisions making Phyto-cannabinoid medicines available to patients in India & Globally.

Their products have proven results in curing Opioid crisis, Cholesterol, BP, Diabetes, sleeping disorders, Anxiety, Depression, Arthritis pain, Chronic Pain, Neuropathic Pain, Epilepsy, Parkinson & Alleviates Cancer Chemotherapy side effects. Cannabis based medicines have huge potential that are still to be explored. With good team of medical practitioners, research scholars and experts, Cannarma is fine tuning of the formulations to give much better results to patients. Through word-of-mouth benefits of these medicines are witnessing leading of exponential growth in sales. Company’s Therapeutic & Medicinal grade formulations are approved by scientific board of Researchers, Ayurveda experts, Doctors, Pharmacists & Biologists. Many new products are in pipeline which will be launched soon through different brand names. Increasing efficiency of Support services have also been worked upon to cater to the growing needs of patients.

Considering the aspirations of Company there were need to have a good management oversight and strategic guidance. To fulfil this need, Mr. Prakash Khalate and Dr. Deepak Pant were appointed as Board of Advisor. Rohit and Keshav along with Board of Advisors are an integral part of decision-making process of the company. Mr Prakash is doyen of Pharmaceutical industry with 32 years of experience in pharma domain and is part of leadership team in various companies. His experience in driving success of Dhanwantari Distributors Pvt. Ltd came handy while marketing and branding strategies were revamped. His judgement and proven connections in industry have helped to build robust distribution channels.

Cannarma is scaling its operations under the able guidance of its leadership team. On the Other Side National Award winner for Technology Innovation by the President of India to Dr. Deepak Pant – working on the Multi-year University research project collaboration between the Central University of Himachal Pradesh, INCARE LAB, CANNARMA & IGMC-Shimla (Indira Gandhi Medical College & Hospital, H.P) in the area of using Cannabis Plant Science and Medicinal Cannabis products for pharmacological benefits and detoxification studies.

The vision of Cannarma is to be a leading Medicinal Cannabis pharmaceutical company that offers high-quality and innovative medicinal solutions based on Cannabis. Rohit and Keshav want to achieve this goal by providing high-standard production and quality products. The company wants to exceed the expectations of their customers by offering good health care via affordable medicines.

For more information visit: https://cannarma.com/

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business Tags:Business

Post navigation

Previous Post: SVP Global Textiles Ltd Reports Income of Rs. 294.10 crore in Q2FY23
Next Post: Bollywood stars grace Trailer launch of Manish Sharma’s web series L… Lag Gaye

Related Posts

  • OneWave Launches Asset-Backed Investment Initiative at Dubai Summit Business
  • Nick Cassidy Triumphs In Monaco To Take Formula E World Championship Lead – 2023 Monaco E-Prix Report Business
  • Indian market has the potential to be the next growth frontier for Taiwan Business
  • Khanna Gems Group Introduces TheSpiritualClinic.com Aura Testing Centres Business
  • AB de Villiers becomes the face of FairPlay Business
  • Teckinfo Solutions Pvt. Ltd., a leading software provider to call centres, Launches ID Cloud – Premium Contact Center Solution Business

Recent Posts

  • Galaxy Recover: Fight Cyber Threats Before They Strike with Proactive Protection
  • GoSats Integrates with Flipkart SuperCoins to Enable Asset-linked Rewards for Indian Users
  • Ehime Fish Festival 2026 Brings Japan’s Iconic Yellowtail to Mumbai in a Landmark Culinary Celebration
  • Mitsu Chem Plast Limited Posts Robust Q3 FY26 Performance EBITDA Rises 73 Percent, Net Profit Up 217 Percent YoY
  • K J Somaiya Institute of Management Recognised by CSRI for Advancing India’s Sports Education Ecosystem

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Farmer’s daughter Dr. Pooja Singh receives Global Young Scientist Award for her work on creating tiles from factory ash National
  • Remedium Lifecare Limited Bonus Share Buzz Business
  • Texaro Sanitaryware Expands Its Horizons to Karnataka Business
  • WhatsApp Bans Over 8 Million Indian Accounts in a Month: Here’s Why Technology
  • Ritika Gulatis first music album Hukum, song out now Entertainment
  • Empowering Women & Driving Change – Here’s a list of the Top 5 women entrepreneurs in India Business
  • Dr. Sudhir Srivastava Inspires Cardiac Surgeons to Be Future-Ready by Upskilling Themselves in New and Emerging Technologies Business
  • Apollo Techno Industries Limited files DRHP for IPO: Advocates sustainability in listing on a stock exchange Finance

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme